NeoGenomics Inc (NEO)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	660,566	644,118	628,248	610,663	591,643	574,796	551,624	529,779	509,728	496,755	489,313	485,965	484,329	484,594	488,698	453,951	444,448	425,319	404,547	419,283
Total assets	US$ in thousands	1,638,040	1,641,110	1,643,280	1,640,340	1,681,230	1,678,240	1,695,110	1,709,170	1,740,030	1,755,580	1,792,110	1,829,550	1,869,780	1,906,390	1,896,310	1,494,410	988,331	959,428	945,485	732,247
Total asset turnover		0.40	0.39	0.38	0.37	0.35	0.34	0.33	0.31	0.29	0.28	0.27	0.27	0.26	0.25	0.26	0.30	0.45	0.44	0.43	0.57

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $660,566K ÷ $1,638,040K
= 0.40

The total asset turnover ratio for NeoGenomics Inc has shown some fluctuations over the period from March 31, 2020, to December 31, 2024. The ratio measures how efficiently the company is generating sales revenue from its assets.

NeoGenomics Inc's total asset turnover ratio ranges from 0.26 to 0.57 during this period. The ratio decreased from 0.57 on March 31, 2020, to 0.40 on December 31, 2024. This decline indicates that the company's ability to generate sales from its assets has weakened over time.

It is essential for NeoGenomics Inc to closely monitor and manage its asset turnover ratio to ensure optimal utilization of its assets to generate revenue. Further analysis of the company's operational efficiency and asset management strategies may be necessary to improve this ratio and enhance overall financial performance.